CA2316052A1 - Formules de peptides hydrosolubles a liberation continue - Google Patents
Formules de peptides hydrosolubles a liberation continue Download PDFInfo
- Publication number
- CA2316052A1 CA2316052A1 CA002316052A CA2316052A CA2316052A1 CA 2316052 A1 CA2316052 A1 CA 2316052A1 CA 002316052 A CA002316052 A CA 002316052A CA 2316052 A CA2316052 A CA 2316052A CA 2316052 A1 CA2316052 A1 CA 2316052A1
- Authority
- CA
- Canada
- Prior art keywords
- sustained release
- water soluble
- release formulations
- soluble peptides
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002535463A CA2535463A1 (fr) | 1989-07-07 | 1990-07-05 | Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37702389A | 1989-07-07 | 1989-07-07 | |
US377,023 | 1989-07-07 | ||
US41134789A | 1989-09-22 | 1989-09-22 | |
US411,347 | 1989-09-22 | ||
CA002020477A CA2020477C (fr) | 1989-07-07 | 1990-07-05 | Formules de peptides hydrosolubles a liberation continue |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002020477A Division CA2020477C (fr) | 1989-07-07 | 1990-07-05 | Formules de peptides hydrosolubles a liberation continue |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002535463A Division CA2535463A1 (fr) | 1989-07-07 | 1990-07-05 | Octreotide-pamoate et son utilisation dans des formulations de peptides hydrosolubles a liberation prolongee |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2316052A1 true CA2316052A1 (fr) | 1991-01-08 |
CA2316052C CA2316052C (fr) | 2008-09-02 |
Family
ID=27168773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002316052A Expired - Lifetime CA2316052C (fr) | 1989-07-07 | 1990-07-05 | Formules de peptides hydrosolubles a liberation continue |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2316052C (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008142153A1 (fr) * | 2007-05-24 | 2008-11-27 | Novartis Ag | Composition à libération modifiée comprenant un dérivé de somatostatine en microparticules |
US8999390B2 (en) | 2008-01-30 | 2015-04-07 | Novartis Ag | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
EP3242318A1 (fr) * | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Produit monodispersé de microstructure ou de nanostructure |
CN111514118A (zh) * | 2020-05-06 | 2020-08-11 | 南京林业大学 | 一种葡萄糖改性的聚乳酸立构复合物载药微球制备方法及产品 |
-
1990
- 1990-07-05 CA CA002316052A patent/CA2316052C/fr not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3242318A1 (fr) * | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Produit monodispersé de microstructure ou de nanostructure |
US10842748B2 (en) | 2003-12-19 | 2020-11-24 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography |
US11642313B2 (en) | 2003-12-19 | 2023-05-09 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography |
WO2008142153A1 (fr) * | 2007-05-24 | 2008-11-27 | Novartis Ag | Composition à libération modifiée comprenant un dérivé de somatostatine en microparticules |
US9351923B2 (en) | 2007-05-24 | 2016-05-31 | Novartis Ag | Extended-release composition comprising a somatostatin derivative in microparticles |
EP3666263A1 (fr) * | 2007-05-24 | 2020-06-17 | Recordati AG | Une composition à libération controlée qui contient une dérivé de somatostatine dans les microparticules |
US8999390B2 (en) | 2008-01-30 | 2015-04-07 | Novartis Ag | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
CN111514118A (zh) * | 2020-05-06 | 2020-08-11 | 南京林业大学 | 一种葡萄糖改性的聚乳酸立构复合物载药微球制备方法及产品 |
Also Published As
Publication number | Publication date |
---|---|
CA2316052C (fr) | 2008-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY106722A (en) | Sustained release formulations of water soluble peptides. | |
FI870155A0 (fi) | Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi | |
CA2207078A1 (fr) | Derives de l'insuline fixant davantage de zinc | |
WO1995013297A3 (fr) | Compositions immunogenes ameliorees agissant contre la gastrine humaine 17 | |
EP0332222A3 (fr) | Delivrance intravaginale des polypeptides biologiquement activs | |
PH30995A (en) | Sustained release formulations of water soluble peptides. | |
HUP0000737A2 (hu) | Hialuronsav mikrorészecskékbe foglalt hatóanyagokat tartalmazó nyújtott hatóanyagleadású készítmény | |
UA35569C2 (uk) | Композиція для пролонгованого і контрольованого вивільнення пептидної лікарської речовини і спосіб її одержання, спосіб приготування суспензії, що призначена для парентерального введення | |
AU624494B2 (en) | A method of preparing a freeze-dried formulation containing a drug | |
CA2128199A1 (fr) | Compositions pharmaceutiques, solides, stables, renfermant du maleate d'enalapril | |
HK1029124A1 (en) | Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them. | |
RU94005001A (ru) | Лиофилизат на основе пептида | |
EP0211601A3 (fr) | Stabilisation d'hormones de croissance | |
CA2316052A1 (fr) | Formules de peptides hydrosolubles a liberation continue | |
CA2356959A1 (fr) | Systeme de distribution de medicament insoluble dans l'eau | |
EP0369474A3 (fr) | Composition pharmaceutique pour le traitement de l'oedème cérébral | |
WO1988003150A3 (fr) | Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale | |
FI991120A (fi) | Vesiliukoisten peptidien pitkäaikaisesti vapautuvat koostumukset | |
ZA9710254B (en) | LH-RH peptide analogues, their uses and pharmaceutical composition containing them. | |
CA2239313A1 (fr) | Compose solide, sa preparation et son utilisation en medecine | |
ES2049617A1 (es) | Procedimiento de preparacion de una composicion farmaceutica. | |
CA2021923A1 (fr) | Compose pharmaceutique contenant un derive d'hydantoine | |
CA2036657A1 (fr) | Synthese d'analogues de lh-rh assurant une protection minimale temporaire | |
RU97120940A (ru) | Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе | |
RU96111534A (ru) | Пищевая биологически активная добавка тинростим-с |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |